Volume 73 Number 7 November 2006	back to contents

¹Institute of Medicine, Chung Shan Medical University, Taichung, ²Hung Kuang University, Taichung, ³Division of Endocrinology and Metabolism, Veterans General Hospital-Taipei, ⁴School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, ⁵Department of Hemaoncology, Show Chwan Memorial Hospital, Changhua, Taiwan, Republic of China.

Address all correspondence to Yih-Hsin Chang, Ph.D., Professor/Chair, School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402, Taiwan, Republic of China; e-mail: cyh@csmu.edu.tw.

Accepted for publication April 2006.

Abstract

Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disorder of unknown etiology. It has been suggested that metalloproteinases (MMPs) play important roles in the development and complications of autoimmune disorders. This article presents our research on the expression or activities of MMPs in Taiwanese T1DM patients.

Methods: Levels and activities of plasma MMP-2 and MMP-9 in patients with T1DM were investigated and compared to those of control individuals by enzyme-linked immunosorbent assay and zymography.

Results: Circulatory levels and activities of MMP-2 and MMP-9 in patients with T1DM were significantly higher than those in control subjects.

Conclusions: MMP expression and activities are significantly increased in patients with T1DM. Our results not only document plasma MMPs levels and activities in the Taiwanese population (with a very low type 1 diabetic incidence), but also suggest that MMP expression and activity are elevated before the onset of complications in diabetic patients.

Key Words

Matrix metalloproteinase-2, matrix metalloproteinase-9, type 1 diabetes mellitus, diabetes.

MSSM Home

Back Issues | Indexes | Search | Journal Home